AbbVie sees hit to Humira sales from European competition
U.S. drugmaker AbbVie Inc on Friday lowered its forecast for overseas sales of its top-selling medicine, Humira, due to larger-than-expected pricing cuts because of new competition in Europe.
U.S. allows eight ‘jurisdictions’ to keep buying Iran oil for now
The United States said on Friday it will temporarily allow eight jurisdictions to keep importing Iranian oil when U.S. sanctions come back into force on Monday, sparing them for now from the threat of U.S. economic penalties.
Economy glides, but fading ‘Trump bump’ may cast shadow over 2020 race
President Donald Trump’s bet that tax cuts and a gush of government spending would smooth the path to a second term may falter as cracks begin to appear in a decade-old recovery.
Broadcom makes $1 billion patent claim against Volkswagen: Der Spiegel
U.S. semiconductor supplier Broadcom has made a patent claim for more than $1 billion against Volkswagen and is threatening to seek a judicial ban on the production of several car models, German magazine Der Spiegel said on Friday.
SEC collects nearly $4 billion in fines, disgorgement in fiscal 2018
The Securities and Exchange Commission assessed $3.945 billion in disgorgement and penalties across 821 enforcement actions in fiscal 2018, the agency’s enforcement division said in its annual report on Friday.
U.S. job growth jumps; annual wage gain largest since 2009
U.S. job growth rebounded sharply in October and wages recorded their largest annual gain in 9-1/2 years, pointing to further labor market tightening that could encourage the Federal Reserve to raise interest rates again in December.
Wall Street lower as Apple extends slide
U.S. stocks gave up early gains to trade lower on Friday morning, as Apple extended losses and dragged down technology stocks after it gave a disappointing forecast, adding to fears of a slowdown in corporate growth.
Wall St. higher for fourth day on trade deal hopes, but Apple drags
The Dow and the S&P rose for a fourth straight day on Friday, lifted by strong earnings and optimism that the United States and China were trying to resolve their trade dispute, but Apple’s slide after a disappointing forecast curbed gains and pulled the Nasdaq lower.
AbbVie lifts profit target after cancer drug powers quarterly beat
AbbVie Inc beat Wall Street estimates for third-quarter profit on Friday, driven by strong sales of blockbuster cancer medicine Imbruvica, and the drugmaker raised its 2018 earnings forecast, sending its shares up 4 percent.
Humira biosimilars available at up to 80 percent discount in Europe: AbbVie
AbbVie Inc said on Friday rival biosimilar versions of its best-selling drug Humira were available in Europe at discounts ranging from 10 percent to 80 percent.
